November 19, 2014 | By Márcio Barra
The newly release Ordinance No. 231-A / 2014 of November 12 just issued the new benchmark countries for 2015 to calculate drug prices in Portugal. The upcoming drug pricing revision will be made by referencing the values practiced in Slovenia, Spain and France. Last year1s reference countries were Spain, France and Slovakia. This revision will affect the prices of all non-generic drugs and drugs that will be launched in 2015. The ordinance also states that the price of generic drugs will not increase in 2015.
This is the third change since the implementation of the rotating reference pricing system, as decreed by Decree-Law No. 112/2011, of November 29, and the enactment of the Memorandum of Understanding between Portugal and Troika in 2011.
Up until 2011, the reference countries were France, Spain, Italy and Greece. In 2013, they were Spain, Slovenia and Italy, and in 2014, Spain, France and Slovakia were the 3 chosen by the Portuguese Ministry of Health.